STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' DEFICIT - USD ($) $ in Thousands |
Preferred Stock
Series m Preferred Stock
|
Preferred Stock
Series m-1 Preferred Stock
|
Preferred Stock
Series m-2 Preferred Stock
|
Preferred Stock
Series m-3 Preferred Stock
|
Preferred Stock
Series m-4 Preferred Stock
|
Preferred Stock
Series S Preferred Stock
|
Preferred Stock
Series A Preferred Stock
|
Preferred Stock
Series B Preferred Stock
|
Common Stock
Class A Common Stock
|
Common Stock
Class B Common Stock
|
Additional Paid-in-capital |
Accumulative Deficit |
Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance as of beginning at Dec. 31, 2020 | $ 13,866 | $ 4,982 | $ 46 | $ 5,826 | $ 27,135 | $ 3,865 | $ 9,442 | ||||||
Balance as of beginning (in shares) at Dec. 31, 2020 | 5,339,215 | 1,660,756 | 16,757 | 1,432,786 | 3,731,248 | 8,936,015 | 4,653,583 | ||||||
Increase (decrease) in temporary equity | |||||||||||||
Warrants Exercised | $ 1,319 | ||||||||||||
Warrants Exercised (in shares) | 186,872 | ||||||||||||
Issuance of Series s Preferred Stock, net of issuance costs | $ 16,545 | ||||||||||||
Issuance of Series s Preferred Stock, net of issuance costs (in shares) | 1,855,904 | ||||||||||||
Share conversion to common stock | $ (1,985) | $ (1,227) | $ (6,434) | $ (13,685) | $ (1,202) | $ (1,883) | $ 6 | $ 3 | $ 26,407 | $ 26,416 | |||
Share conversion to common stock (in shares) | (764,298) | (409,090) | (1,432,786) | (1,881,913) | (2,780,451) | (927,491) | 5,932,533 | 2,942,197 | |||||
Series m-4 accrued dividend | $ 608 | $ (608) | $ (608) | ||||||||||
Balance at the end at Dec. 31, 2021 | $ 11,881 | $ 1,319 | $ 3,755 | $ 46 | $ 29,995 | $ 2,663 | $ 7,559 | ||||||
Balance at the end (in shares) at Dec. 31, 2021 | 4,574,917 | 186,872 | 1,251,666 | 16,757 | 3,705,239 | 6,155,564 | 3,726,092 | 19,617,107 | |||||
Balance as of beginning at Dec. 31, 2020 | $ 10 | 3,051 | (69,246) | $ (66,185) | |||||||||
Balance as of beginning (in shares) at Dec. 31, 2020 | 10,189,000 | ||||||||||||
Increase (decrease) in stockholders' equity | |||||||||||||
Stock based compensation | 1,269 | 1,269 | |||||||||||
Warrants expired | 14 | 14 | |||||||||||
Stock options exercised | 4 | $ 4 | |||||||||||
Stock options exercised (in shares) | 4,396 | 4,396 | |||||||||||
Net loss | (43,843) | $ (43,843) | |||||||||||
Balance as of end at Dec. 31, 2021 | $ 6 | $ 13 | 30,745 | (113,697) | $ (82,933) | ||||||||
Balance as of end (in shares) at Dec. 31, 2021 | 5,936,929 | 13,131,197 | |||||||||||
Increase (decrease) in temporary equity | |||||||||||||
Share conversion to common stock | $ (7,063) | $ (1,319) | $ (3,275) | $ (46) | $ (8,018) | $ (1,328) | $ (386) | ||||||
Share conversion to common stock (in shares) | (2,719,589,000) | (186,872,000) | (1,091,666,000) | (16,757,000) | (990,507,000) | (3,069,404,000) | (190,471,000) | ||||||
Balance at the end at Dec. 31, 2022 | $ 4,818 | $ 480 | $ 21,977 | $ 1,335 | $ 7,173 | ||||||||
Balance at the end (in shares) at Dec. 31, 2022 | 1,855,328,000 | 160,000,000 | 2,714,732,000 | 3,086,160,000 | 3,535,621,000 | 11,351,841 | |||||||
Increase (decrease) in stockholders' equity | |||||||||||||
Stock based compensation | 3,539 | $ 3,539 | |||||||||||
Warrants exercised | 370 | 370 | |||||||||||
Warrants exercised (in shares) | 156,483,000 | ||||||||||||
Conversion of debt obligations to Class A Common Stock | $ 7 | 16,004 | 16,011 | ||||||||||
Conversion of debt obligations to Class A Common Stock (in shares) | 6,513,385,000 | ||||||||||||
Stock options exercised | 551 | $ 551 | |||||||||||
Stock options exercised (in shares) | 370,235,000 | 25,000,000 | 395,235 | ||||||||||
Offering proceeds net of issuance costs | $ 2 | 19,623 | $ 19,625 | ||||||||||
Offering proceeds, net of issuance costs (shares) | 2,236,619,000 | ||||||||||||
Shares issued for consulting services | 653 | 653 | |||||||||||
Shares issued for consulting services (in shares) | 236,567,000 | ||||||||||||
Proceeds from equity sale, net of issuance costs | $ 1 | 2,878 | 2,879 | ||||||||||
Proceeds from equity sale, net of issuance costs (in shares) | 1,307,950,000 | ||||||||||||
Share conversion costs | (74) | (74) | |||||||||||
Share conversion to common stock | $ 12 | $ (3) | 21,427 | 21,436 | |||||||||
Share conversion to common stock (in shares) | 11,271,070,000 | (2,836,313,000) | |||||||||||
Net loss | (25,643) | (25,643) | |||||||||||
Balance as of end at Dec. 31, 2022 | $ 28 | $ 10 | $ 95,716 | $ (139,340) | $ (43,586) | ||||||||
Balance as of end (in shares) at Dec. 31, 2022 | 28,029,238,000 | 10,319,884,000 |